Literature DB >> 7304660

Sudden death associated with thyroid hormone abuse.

S Bhasin, W Wallace, J B Lawrence, M Lesch.   

Abstract

Three patients with hyperthyroidism due to deliberate intake of excessive amounts of L-thyroxine are described wherein death was "instantaneous" and presumably due to ventricular fibrillation. Hyperthyroidism was not recognized on admission in two of these patients because of atypical presentations. Autopsy was performed in two patients. In one patient no coronary disease was present and focal myocarditis with leukocytic infiltration was noted. The second patient had an acute posterior myocardial infarction due to acute coronary thrombosis, but focal areas of leukocytic infiltration and fibrosis were also seen in the anterior wall not involved in the process of infarction. Factitious hyperthyroidism due to L-thyroxine abuse can be associated with sudden death in the absence of coronary artery disease and may be related to a drug induced myocarditis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304660     DOI: 10.1016/0002-9343(81)90392-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

1.  Lethal thyroid storm after uncontrolled intake of liothyronine in order to lose weight.

Authors:  Benno Hartung; Matthias Schott; Thomas Daldrup; Stefanie Ritz-Timme
Journal:  Int J Legal Med       Date:  2010-02-10       Impact factor: 2.686

Review 2.  Impact of concomitant medications on obstructive sleep apnoea.

Authors:  Ingrid Jullian-Desayes; Bruno Revol; Elisa Chareyre; Philippe Camus; Céline Villier; Jean-Christian Borel; Jean-Louis Pepin; Marie Joyeux-Faure
Journal:  Br J Clin Pharmacol       Date:  2016-11-24       Impact factor: 4.335

3.  Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management.

Authors:  An Jacobs; Inge Derese; Sarah Vander Perre; Esther van Puffelen; Sören Verstraete; Lies Pauwels; Sascha Verbruggen; Pieter Wouters; Lies Langouche; Gonzalo Garcia Guerra; Koen Joosten; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  Thyroid       Date:  2019-03-11       Impact factor: 6.568

Review 4.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

5.  Central and peripheral molecular targets for antiobesity pharmacotherapy.

Authors:  M A Valentino; J E Lin; S A Waldman
Journal:  Clin Pharmacol Ther       Date:  2010-05-05       Impact factor: 6.875

Review 6.  Clinical features and management of overdosage with thyroid drugs.

Authors:  T H Lin; R T Kirkland; J L Kirkland
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

Review 7.  Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects.

Authors:  Gayane Sargis Vardanyan; Hasmik Samvel Harutyunyan; Michail Iosif Aghajanov; Ruben Sargis Vardanyan
Journal:  Future Med Chem       Date:  2020-10-12       Impact factor: 3.808

8.  Massive thyroxine intoxication: evaluation of plasma extraction.

Authors:  J Binimelis; L Bassas; L Marruecos; J Rodriguez; M L Domingo; P Madoz; S Armengol; M A Mangues; A de Leiva
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 9.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

10.  A thyrotoxicosis outbreak due to dietary pills in Paris.

Authors:  Vincent Ioos; Vincent Das; Eric Maury; Jean-Luc Baudel; Jérôme Guéchot; Bertrand Guidet; Georges Offenstadt
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.